| Avandamet Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Avandamet 500 mg-1 mg | tablet | oral | 1.0 each | OTC |
| Avandamet 500 mg-4 mg | tablet | oral | 1.0 each | OTC |
| Avandamet 1000 mg-2 mg | tablet | oral | 1.0 each | OTC |
| Avandamet 500 mg-1 mg | tablet | oral | 1.0 each | OTC |
| Avandamet 500 mg-2 mg | tablet | oral | 1.0 each | OTC |
Eisai/Pfizer's Aricept Owns a Dominating 42.4% Patient Share for ... - Earthtimes
Pathway to key therapies from previous therapies (eg, how much Avandamet use is preceded by metformin, Avandia, or both as single products?). ...
Mon Feb 04 08:24:59 -0500 2008
Tainted Pills Hit US Mainland - The Associated Press
... in FDA history and also collected tablets of the diabetes treatment Avandamet after some were found not to have accurate doses of the active ingredient. ...
Tue Feb 05 20:11:17 -0500 2008
GlaxoSmithKline To Revise Avandia® (rosiglitazone Maleate) Label ... - Medical News Today (press release)
The label changes will be applied to all approved rosiglitazone-containing products: Avandia ® (rosiglitazone maleate), Avandamet ® (rosiglitazone maleate ...
Mon Jan 28 03:05:01 -0500 2008
metformin hydrochloride - The hydrochloride salt form of metformin, a biguanide with antihyperglycemic activity. Metformin hydrochloride exerts its action by improving hepatic sensitivity to insulin, thereby suppressing hepatic glucose production and increasing hepatic glycogen stores. In addition, metformin hydrochloride increases the number and/or affinity of insulin receptors on cell surface membranes in muscle and adipose tissue, thereby increasing the sensitivity to insulin at receptor and post-receptor binding sites and increasing glucose uptake peripherally.
rosiglitazone maleate